Application of Ackermann muciniphila in preparation of composition for improving metabolic syndrome

By using drugs or health care compositions prepared by Akmangii mucophilin AM06 and AM02, the side effects and multiple symptoms of metabolic syndrome treatment are solved, and effective prevention and treatment of metabolic syndrome is achieved.

CN119656203APending Publication Date: 2025-03-21GUANGZHOU ZHIYI PHARMA INC
0 Cites 0 Cited by

Patent Information

Application Number
CN202411695566.0
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2022-06-08
Publication Date
2025-03-21

AI Technical Summary

Technical Problem

The existing treatments for metabolic syndrome have side effects and are unable to take into account multiple symptoms, and individual differences in patients lead to lifestyle intervention compliance issues.

Method used

Using mucophilin Akmangi AM06 and AM02, pharmaceutical compositions or health care products are prepared as medicines or health care foods for preventing or improving metabolic syndrome.

Benefits of technology

Akmania mucophilin can reduce obesity, reduce insulin resistance, regulate blood pressure, improve blood sugar and blood lipid metabolism, and effectively prevent and treat metabolic syndrome.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention relates to application of Akkermania muciniphila AM02 in preparation of a composition for improving metabolic syndromes, in particular to application of Akkermania muciniphila AM02 in preparation of a composition for improving metabolic syndromes, and application of Akkermania muciniphila AM02 in preparation of a composition for improving metabolic syndromes in preparation of a composition for improving metabolic syndromes in preparation of a composition for improving metabolic syndromes in preparation of a composition for improving metabolic syndromes in preparation of a composition for improving metabolic syndromes. Wherein the preservation number of the Akkermansia muciniphila AM02 is CGMCC (China General Microbiological Culture Collection Center) No.22794, and the preservation number of the Akkermansia muciniphila AM02 is CGMCC No.22794. In the application, the composition can relieve obesity degree and insulin resistance of rats, regulate blood pressure, improve blood sugar and blood lipid metabolism, and effectively prevent and treat metabolic syndrome.
Need to check novelty before this filing date? Find Prior Art